David Zidar, MD
Showing of 2 results
Clinical Trial at UH Seeks to Improve Outcomes for TAVR Patients
Two anti-platelet drugs studied for their effect on platelet function and immune activation post-procedure Innovations in Cardiovascular Medicine & Surgery - Fall 2018 David A. Zidar, MD, PhD Transcatheter aortic valve replacement (TAVR) has...
Making the Case for CT CORONARY CALCIUM SCORING
Innovative, no-cost program increases access to vital test Harrington Heart & Vascular Institute Innovations - Spring 2016, updated January 2017 David A. Zidar, MD, PHD Robert C Gilkeson, MD Preventive cardiologists continue to refine their risk...
Results are loading...